Summary The DOM project is a non-randomized population-based breast cancer screening programme in Utrecht which started in 1974-75.
The purpose of the present paper is to evaluate long-term benefits of the breast cancer screening in the DOM project in The Netherlands. bv means of a nested case-control studv. Ex aluation Awas made of t-o particular forms of bias to which attention has recent1s been drawn (Hosek et al. 1996; Weiss and Lazoxich. 1996) .
SUBJECTS AND METHODS
The DOM [Diacnostisch Onderzoek (investigation) Mammacarcinoom] project started in December 1974 in the city of Utrecht. Initiallv. the screening A-as limited to A-omen aged [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] at intake (birth cohort 191 1-25) . and thev A-ere screened bv mammography. Of 20 555 eligible A-omen. 14 697 (72%7c) attended for screening. The intervals between successive screening examinations (screens) w-ere of different length. namelv 1. 1'/,. 2 and 4 x-ears. At the first examination. both mediolateral and craniocaudal projections A-ere obtained: in subsequent examinations. mammographx w as restricted to the mediolateral projection. A w-oman who did not participate in the first screeningv was not invited for the second screening and so on.
Fix e examinations had been completed by 1984. A breast cancer registry was set up and cooperation w-ith general practitioners. local authorities and the Central Bureau for Statistics (CBS) ensured the followi-up of the invited A-omen. More detailed information about the screening design has been described prexiously (Collette et al. 1984 . 1992 (Weiss and Lazovich. 1996) . was ealuated by excluding breast cancer deaths wvith a short follovi-up period after diacnosis (i.e. deaths of patients wvho viere less likely to hax-e been screened). because their inclusion wiould gixe the impression of a disproportionately large number of deaths from breast cancer in unscreened wvomen. Maximum likelihood estimation of the odds ratio (OR) associated with breast cancer screeningr was obtained (Breslow and Dav. 1980 However. the confidence intervals of the ORs are broad and these differences are not statisticallI significant.
In Table 3 . ORs are shou-n for different intervals betu-een the last screenina examination and diagnosis of the case. the number of screens. and participation in all offered screens before or at diacnosis of the case. W'omen w-ho never participated (87 cases and 193 controls) represented the reference group. The strongest protectix e effect was found for the interval of 2 years or less betuA-een the last screen and diagnosis of the case (OR 0.38. 95%'-confidence interval 0.18-0.77). The protection of screeninee decreased u-ith increasincg interxal periods since the last screen. Writh reaard to the number of screens. the ORs decreased with increasincg number of screens before diagnosis of the case. The OR for women who participated in all offered screens was lower than the OR for women without full compliance. In the present case-control study. all screening xisits up to. and includina. the diaenosis were counted as a positix e x-isit. For the screen-detected cases (n = 23). the screening, examination. from which the diagnosis was made. was included as part of the screening, histor-. To evaluate the possible bias due to including this examination. an analy sis of the same data (177 matched case-control pairs) was performed. excluding the diaonostic screening, examination. This gave an OR of 0.38 (95%e confidence interval 0.26-0.56). suggesting a higher protectix e effect of screening.
To evaluate lead-time-bias'. Table 4 show-s the influence of excluding cases with successively longer follow -up times betmeen diagnosis and dying. If this period is less than 1 year. the effect of screening seems to be overestimated.
DISCUSSION
This case-control approach indicates a 46%e reduction in breast cancer mortalitv after 17 years of follow--up for participants of the screening programme. The strongest protective effect of screenine is found in the oldest birth cohort. women of 60-64 years at the start of the project. A higher lexel of protection in older women has been described earlier in the DOM project (Collette et al. 1984 (Collette et al. . 1985 (Collette et al. . 1992 and in other studies (Tabar et al. 1995) . Cancers detected at screening wxould be expected to be of lower malignant British Joumal of Cancer (1998) 78(7). [962] [963] [964] [965] 0 Cancer Research Campaign 1998 Table 2 . Selection bias due to a 'healthv screenee effect' cannot be excluded in this case-control study. because both the number of screenings before diagnosis of the case and compliance show protective effect (Table  3) . Two other forms of bias in a case-control desien may also be relevant. 'Misclassification of exposure' bias due to includine the screening examination. from which the diaenosis was made. in the screenin2 history of the screen-detected cases (Hosek et al. 1996) appears to be present in the current study. Its effect is reflected in an OR of 0.54 (with inclusion of the diagnostic screening: 95C% confidence interval 0.37-0.79) and 0.38 (without screening: 95%7s confidence interval 0.26-0.56). The unbiased OR may be expected to lie between the two estimates. because systematic exclusion of the screening examination can cause bias in the opposite direction to that of its inclusion (Hosek et al. 1996) . The other form of bias. lead-time bias'. seems also to be present in this study. Too short a follow-up time of incident cases leads to an artificially large number of deaths from breast cancer in unscreened cases (in w-hich lead time is absent). resultina in an overestimation of the protective effect (Weiss and Lazovich. 1996 (Collette et al. 1984 (Collette et al. . 1985 (Patnick et al. 1995 : Asburv et al. 1996 . On the basis of the results of the present study (Table 3) . a 2-yearly screening programme seems preferable to a 3-yearly proaramme. However. these results should be interpreted with caution because of the small number of cases and controls with an interval of 2-3 years between last screen and diaognosis of the case.
In the present study. In conclusion. early diagnosis of breast cancer by screenin2 reduces breast cancer mortality-in the longyer term. Tw-o forms of bias due to the case-control study design seem to influence the protective effect in different directions: the overall bias probably results in a small overestimation of the overall protective effect.
The choice of a 2-yearly interval in the nationwide Dutch screening programme is supported by the results of the present study.
